InvestorsHub Logo
Followers 34
Posts 2480
Boards Moderated 0
Alias Born 02/04/2013

Re: plexrec post# 144767

Thursday, 03/15/2018 9:57:54 AM

Thursday, March 15, 2018 9:57:54 AM

Post# of 461196
Ok, I could not respond to the posts yesterday as I was over my 3 post limit. Yes I did speak with DR. M. Like I said before the squeaky wheel gets the oil. We had a 15 min conversation and I came away very positive. Here is what he confirmed to me.
1. He believes the stock is undervalued and will adjust when the trials start and the data for biomarkers and genome is released. Big stuff I guess.
2. IND has been resubmitted to FDA and it is in their hands. So hopefully any day now for approval. He made a point to say that they are in good hands with the new FDA guy they hired.
3. No basket trials. He said that the epilepsy differences in Rett, Angelman, etc are too great and have different characteristics. He said it was more in line for cancer treatments.
4. He said much of the wait time has been out of their hands. Waiting for the new rules from FDA slowed things down but will help in the long run.
5. I asked him about $$ and he confirmed they have enough and will be expecting $$ to come from Australian Govt., Rett Association and Parkinson Foundation. He reiterated that they are not expensive trials in comparison to how others have been run.

If I remember anything else I will post but I am continuing to be a strong believer and will be holding. Not adding because I have way too much already.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News